Brazilian Coronary ARtery Disease — BARD  

Coronary Artery Disease Clinical Trial

Official title: The Brazilian Coronary Disease Cohort

Status Not yet recruiting

Clinical Trial Summary

Although coronary artery disease may have a stable chronic clinical course, it is known that this reality does not apply to atherosclerotic plaques, they can grow, complicate, stabilize and again start new cycles of growth/destabilization/stabilization or quiescence in the presence or absence of symptoms. While in obstructive coronary lesions there are well-founded guidelines based on multiple clinical studies, in relation to investigation and treatment; on the other hand, in non-obstructive lesions, there are no such guidelines. There are gaps in the knowledge about the prognostic implications of minor injuries and the occurrence of events. This study seeks precisely to fill these knowledge gaps. Of particular relevance are the large number of patients (approximately 10,000 patients) and the long clinical follow-up, that is, in five years.

Clinical Trial Description

Introduction:

For decades, patients with obstructive coronary disease, specifically with lesions above 70%, have been the subject of numerous randomized studies and meta-analyses concerning the influence of drug treatments, revascularization (surgical or percutaneous), and lifestyle on their prognosis. In this scenario, the investigators already have a reasonable knowledge of the behaviors most appropriate for both avoiding events and alleviating symptoms. However, one particular subgroup consists of patients whose lesions are non-obstructive. In most cases, these are considered lesions of ≤70%. Many individuals presented obstructive lesions that were deemed appropriate for angioplasty within this classification. For example, in the study Defer of 325 patients with indications of ischemia, 44.3% presented FFR (fractional flow reserve) ≤0.75, which suggested significant obstruction, and were submitted to ATC. Thus, the investigators consider the threshold ≤70% inappropriate since it includes many patients with ischemia when assessed by FFR.

Therefore, this study has decided to investigate patients with lesions of ≤50% on the supposition that they do not have obstructive lesions.

In addition, although coronary disease may follow a stable clinical course, this is not the case with atherosclerotic plaques. These can grow, become complex, stabilize and reinitiate new cycles of growth/destabilization/stabilization or inactivity, in either the presence or absence of evident symptoms. Though aware of this dynamic, studies were performed to "photograph" at a given time subclinical atherosclerotic load and correlate it to the incidence of the events. The indicators most used for evaluating atherosclerotic load have been the presence of extra-cardiac atherosclerosis (carotid ultrasound) and calcification of the coronary arteries.

Furthermore, the calcium score has been used for the same purpose in the Brazilian population: but only as a prognostic indicator among carriers of family hypercholesterolemia.

However, there are considerable doubts concerning therapeutic interventions in asymptomatic patients with no critical stenosis.

Given this gap, chiefly among the Brazilian population, and being an institution with one of the highest volumes of medical care and screening for coronary disease globally, the investigators have all the necessary conditions to put this important public health problem into perspective.

Objectives:

To evaluate clinical evolution, in five years, of patients with no coronary lesions or lesions <50%, invasive coronary angiography (ICA) exams or coronary angiotomography is performed for the diagnosis of coronary disease.

Population:

Patients were referred to Instituto do Coração (InCor HCFMUSP) for ICA or angiotomography for diagnosis of coronary heart disease from January 1, 2011, to December 31, 2017.

Exclusion criteria: age under 18 years or over 80 years at the time of examination, previous history of an acute coronary syndrome (infarction and unstable angina), revascularization interventions (surgical or percutaneous), valvular heart disease, cardiomyopathies, or diseases with a poor prognosis (expected survival of fewer than five years).

The cohort will be composed of 3 groups: the control group (without coronary lesions), lesion group <30%, and lesion group >30% to <50%.

Study type: an observational, retrospective, with data from the database of InCor, (Heart Institute - InCor, University of São Paulo).

Outcomes: primary composite (general death, acute myocardial infarction, cerebrovascular accident, need for revascularization); secondary outcomes: the isolated components of the primary outcome at five years.

Data to be collected:

1. Age (on the date of examination), gender, presence of risk factors - arterial hypertension (BP >130/85; or use of antihypertensive medication), diabetes mellitus (fasting glucose ≥126 mg/dL, casual >140 mg/dL or GTT >200 mg/dL, or use of oral or injectable hypoglycemic agents), dyslipidemia (LDL >130 mg/dL, triglycerides >150 mg), lipid levels (total cholesterol, HDL-C, LDL-C, and triglycerides); tobacco user (never, ex-tobacco user, active), obesity, exercise, family history, creatinine, chronic kidney disease (glomerular filtration <60 mL/1.73m²/min).

2. Medications in use: ACE inhibitors/ARB; statins; AAS; Beta-blockers and calcium channel antagonists, and diuretics.

3. Clinical status: angina and/or dyspnea.

4. Left ventricular systolic function: normal left ventricular ejection fraction (LVEF) (50%), mild decrease (≥45% to <50%); moderate (>35% to 45%) and severe (<35%).

5. Cardiovascular history: cerebrovascular accident or peripheral arterial disease.

6. Atherosclerotic load:

1. Higher percentage of obstruction of the lumen by comparing the diameter in the lesion region with its proximal neighborhood: absent (0%), very mild (1-30%), and mild (30-49%), for eligibility of each group studied;

2. Total lesion score: zero for absence, 1 for minor injuries(<30%), and 2 for minor injuries(30-50%). Multiplied by their frequency and totaled at the end;

3. The atherosclerotic load will be weighted using the Syntax scores for its location, though the lesions are less than 50%. Left coronary trunk = 5; proximal AD = 3.5; medial AD = 1.5; distal AD = 1; diagonal = 1; proximal circumflex = 1.5; distal = 1; marginal = 1; proximal or distal right coronary artery = 1 and posterior descending artery = 1; coronary calcium score (CAC).

Population:

Patients underwent invasive coronary angiography (ICA) or coronary computed tomography angiography at InCor from January 2011 to December 2014. To allow 5-year follow-up (FU) of all cases. The investigators estimate the inclusion of approximately 5,000 patients, with a minimum of 1,500 in the control group.

Deadlines for execution and analysis:

The investigators anticipate including an average of 40 patients per day and completion at the end of 2 years.

The rate of scheduled events should not exceed 0.5% to 1% per year, so the investigators plan interim analyses at two years FU when the investigators would have at least 600 events for analysis.

Clinical, laboratory, and image data:

Electronic Patient Care System SI3 of InCor will be used to screen and follow the patients. Patients who have not been followed regularly at ambulatory clinics of InCor will be contacted by phone or e-mail to ascertain their evolution. In cases of death, family members or attending physicians will be contacted. Death certificates will be analyzed to adjudicate death´s causes.

Eventually, the Foundation for the State System of Data Analysis (SEADE) database from Estado de São Paulo will be used. ;

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia

• NCT number: NCT05392491
• Study type: Observational
• Source: University of Sao Paulo General Hospital
• Contact: Vinícius Quintão, MD
• Phone: 55 11 2661-5795
• Email: vinicius.quintao@hc.fm.usp.br
• Status: Not yet recruiting
• Start date: June 1, 2022
• Completion date: November 1, 2024